Literature DB >> 31838640

Association of juvenile idiopathic arthritis and morphea: a case series.

Teresa Giani1,2, Anna Madera1, Rolando Cimaz3,4.   

Abstract

The association of different autoimmune diseases in the same subject is not uncommon, also in the pediatric age. The coexistence of morphea and juvenile idiopathic arthritis (JIA) is however exceptional. We report four such cases. Unlike the few other reported cases, in 3/4 of our patients, morphea appeared well after the onset of JIA, when the articular disease was in full clinical remission. Based on the epidemiology of pediatric morphea in the general population, this association is unlikely to be fortuitous. Pediatric rheumatologists should be aware of this possible association, and follow clinically patients who achieve long-term clinical remission. Key Points ⦁ Morphea is an unusual occurrence in the context of JIA. These conditions have a common autoimmune background, but are very rarely reported together. ⦁ It is important to follow JIA patients even during long-term remission since other autoimmune phenomena can occur.

Entities:  

Keywords:  Juvenile idiopathic arthritis; Morphea; Scleroderma

Mesh:

Year:  2019        PMID: 31838640     DOI: 10.1007/s10067-019-04850-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  10 in total

1.  Increased prevalence of antithyroid antibodies and subclinical hypothyroidism in children with juvenile idiopathic arthritis.

Authors:  Liora Harel; Dario Prais; Yosef Uziel; Masza Mukamel; Philip Hashkes; Gideon Harel; Jacob Amir; Yehudit Monselise; Joseph Press
Journal:  J Rheumatol       Date:  2006-01       Impact factor: 4.666

2.  Juvenile polyautoimmunity in a rheumatology setting.

Authors:  Clara Malagón; Maria Del Pilar Gomez; Catalina Mosquera; Camilo Vargas; Tatiana Gonzalez; Cristine Arango; Lorena Martin; Pilar Perez; Laura Amaya-Uribe; Nicolas Molano-Gonzalez; Juan-Manuel Anaya
Journal:  Autoimmun Rev       Date:  2019-02-14       Impact factor: 9.754

Review 3.  Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis.

Authors:  Nicole Fett; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2011-02       Impact factor: 11.527

4.  Inflammatory arthritis in pediatric patients with morphea.

Authors:  Sakeen W Kashem; Colleen K Correll; Richard K Vehe; Patricia M Hobday; Bryce A Binstadt; Sheilagh M Maguiness
Journal:  J Am Acad Dermatol       Date:  2018-03-10       Impact factor: 11.527

5.  The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993.

Authors:  L S Peterson; A M Nelson; W P Su; T Mason; W M O'Fallon; S E Gabriel
Journal:  J Rheumatol       Date:  1997-01       Impact factor: 4.666

6.  Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.

Authors:  Kathryn S Torok; Katherine Kurzinski; Christina Kelsey; Jonathan Yabes; Kelsey Magee; Abbe N Vallejo; Thomas Medsger; Carol A Feghali-Bostwick
Journal:  Semin Arthritis Rheum       Date:  2015-06-17       Impact factor: 5.532

7.  Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases.

Authors:  Justin J Leitenberger; Rachael L Cayce; Robert W Haley; Beverley Adams-Huet; Paul R Bergstresser; Heidi T Jacobe
Journal:  Arch Dermatol       Date:  2009-05

8.  Pediatric morphea (localized scleroderma): review of 136 patients.

Authors:  Stéphanie Christen-Zaech; Miriam D Hakim; F Sule Afsar; Amy S Paller
Journal:  J Am Acad Dermatol       Date:  2008-06-20       Impact factor: 11.527

9.  The frequency of autoimmune thyroid disorders in juvenile idiopathic arthritis.

Authors:  Erbil Unsal; Oğuz Oren; Koray Salar; Balahan Makay; Ayhan Abaci; Bayram Ozhan; Ece Böber
Journal:  Turk J Pediatr       Date:  2008 Sep-Oct       Impact factor: 0.552

10.  Autoimmune endocrine disorders and coeliac disease in children and adolescents with juvenile idiopathic arthritis and rheumatic fever.

Authors:  Teresa C Robazzi; Luis F Adan; Kleber Pimentel; Isabel Guimarães; José Magalhães Filho; Maria B Toralles; Ana M Rolim
Journal:  Clin Exp Rheumatol       Date:  2013-02-07       Impact factor: 4.473

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.